A Principle Of Balance: Top Official Explains India’s IP Policy 07/09/2016 by Intellectual Property Watch Leave a Comment Adopted in May, the first Indian intellectual property policy brought some concerns that the focus on IP rights might dampen India’s willingness to use the IP flexibilities to safeguard national policy space. It was also perceived by some as giving in to pressure from the foreign pharmaceutical industry for India to strengthen patent protection. However, a high level Indian official in an interview this week said the policy caters to Indian development needs and India is aware of its pioneering role in certain sectors like access to medicines. Rajiv Aggarwal, Joint Secretary at the Indian Department of Industrial Policy & Promotion Ministry of Commerce & Industry sat down with Intellectual Property Watch’s Catherine Saez to describe how India’s IP policy came into being, to what aim, what it is expected to change in the Indian IP landscape, and how Indian is standing fast to its principle of balance.
US Industry Warns Of Restrictive Policies In ICTs, Including On IP Rights 02/09/2016 by Intellectual Property Watch 1 Comment “Serious concerns” have been raised by the United States Chamber of Commerce that policy measures increasingly restrict investment in the information and communications technology (ICT) sector, following its comprehensive examination of ICT laws and policies around the world. Intellectual property rights are among the areas the Chamber says are being targeted.
Innovation And Access: Fission Or Fusion? Interview With Jennifer Dent, President, BIO Ventures For Global Health (BVGH) 01/09/2016 by Guest contributor for Intellectual Property Watch Leave a Comment In the light of the UN High-Level Panel on Access to Medicines, this series of sponsored articles challenges experts to give their views on the policies that best support the development of solutions to societies’ greatest challenges and how enabling policy environments, including IP systems, influence the development and flow of new technologies and services in different sectors, fields of technology, and jurisdictions. The views expressed in the articles are those of the authors. Below is an interview with Jennifer Dent, President, BIO Ventures for Global Health (BVGH).
Committee Agrees WIPO Strategic Plan To 2021: Possible Rethink For Policymaking 31/08/2016 by Alexandra Nightingale for Intellectual Property Watch and William New 1 Comment Anticipating a degree of uncertainty ahead for the global economy and intellectual property system, the World Intellectual Property Organization in a new six-year strategic plan looks at likely future policy debates, a focus on infrastructure and training, and possible ways to bring about better negotiations at the UN agency.
WHO Debates Expansion Of Role In Virus-Sharing 31/08/2016 by Catherine Saez, Intellectual Property Watch 4 Comments The global treatment of influenza is under reconsideration at the World Health Organization this week, as a review group of a WHO influenza pandemic framework looks at issues such as its relationship with an international treaty protecting countries’ ownership biological resources.
WHO Pandemic Flu Review Group Meets Next Week 24/08/2016 by Catherine Saez, Intellectual Property Watch 2 Comments The review of a World Health Organization mechanism for sharing pandemic influenza viruses while ensuring access to vaccines for developing countries is nearing conclusion. Next week, the reviewers will hold their last meeting, including an open session for governments and stakeholders to share views. The review is addressing issues such as the mechanism’s relationship with other international rules, and how to handle the rising use of genetic data instead of biological samples.
WTO, WHO, WIPO Host Discussions On Antimicrobial Resistance In October 24/08/2016 by Intellectual Property Watch 1 Comment Antimicrobial resistance has been described as a major threat to public health, as infections, even minor, might become killers again, if no new antibiotics are discovered. In October, the World Health Organization, World Intellectual Property Organization and World Trade Organization will join forces for a symposium organised to discuss how to foster innovation, and access.
New US Government Source Code Policy Could Provide Model For Europe 22/08/2016 by William New, Intellectual Property Watch 1 Comment The United States government this month published its new federal source code policy to allow government-wide access to custom source code developed by or for any agency of the federal government. The policy, which aims to reduce duplication, avoid technology “lock-in,” and tap the best minds in or outside government, has caught the attention of free software developers in Europe who are hoping to use it as a basis for change there too.
The Expert On IP For Internet Protocol: Interview With Scott Bradner 19/08/2016 by Intellectual Property Watch 1 Comment Fluent in both types of IP: Scott Bradner has been an architect of intellectual property (IP) policy for internet protocol (IP) standards. He played a core role in the development of internet protocol, leading to the very digital revolution we know today, as well as the next generation IPv6, all the while designing intellectual property policy to go along with it. Here is an interview with Bradner.
The Downfall Of Invention: A Broken Patent System 18/08/2016 by Intellectual Property Watch 1 Comment The cost of dozens of brand-name drugs have nearly doubled in just the past five years. Public outrage over drug prices extends from Capitol Hill to the presidential candidates to patients. In response, pharmaceutical executives are spending more on lobbying and marketing. Yet for all this attention, most of the proposed solutions for reducing prescription drug costs—tougher negotiations, appeals for transparent R&D costs or investigations into insurers—miss one of the primary sources of the problem: the way we award patents, writes Tahir Amin.